Michael Primig PhD in biology

Course and current status

Birth Place & Date: Graz, 08/09/1964

Nationality & Marital status: Austrian/French; married, four children, three grandchildren



1983-1988: Undergraduate, with distinction, University of Vienna, Austria

1988: MS, Institute of Molecular Biology, Austrian Academy of Sciences, Salzburg, Austria

1988-1992: PhD in Molecular Biology, with distinction, Institute of Molecular Pathology, Vienna, Austria


Professional experience

1993-1997: Postdoctoral Fellow, Pasteur Institute, Paris, France

1997-1999: Research Associate/Instructor, The University of Chicago, Chicago, USA

1999-2001: Research Associate, Institute of Human Genetics, Montpellier, France

2001-2007: Assistant Professor & director of the Life Sciences Training Facility, Biozentrum and Swiss Institute of Bioinformatics, Basel, Switzerland

Since 02/2007: Inserm DR2, group leader at Inserm U1085 IRSET, Rennes, France


Honors and Awards

1993-1995             EMBO long-term fellowship (Europe)

1995-1996             Erwin Schrödinger fellowship (Austria)

1996-1997             AFM fellowship (France)

1997-1998             Max Kade fellowship (US/Austria)

2000-2001             FRM fellowship (France)

2002-2007             Swiss Institute of Bioinformatics membership (Switzerland)

2008-2012             Inserm Avenir project of excellence (France)

2011-2014             Prime d'excellence scientifique (France)

2014-2021             Editorial Board Member of Systems Biology in Reproductive Medicine

2018-2021             Editorial Board Member of NPG Scientific Reports 

2022-2026             Member of Inserm CSS2

Scientific summary

Our ongoing work in the field of moleclar oncology focusses on the regulation of EXOSC10/Rrp6 in normal and cancer cells, the roles of Cancer/Testis genes in cancer progression and the identification of drug-responsive regulatory lncRNAs important for cancer cell division and drug resistance.

In the field of gametogenesis we carried out basic research using budding yeast, rat, mouse, and human, which aimed at a better understanding of the regulatory mechanisms that control the meiotic pathway. This work helped identify CT genes with oncogenic potential

In bioinformatics we continue to provide the community with databases

Image d’exemple